Benefits of Nd:YAG 1064 nm laser in the treatment of the face and lower limb telangiectasia

Phase 3

Recruiting

• Conditions: I78.0; Condition 1: Facial telangiectasia. Condition 2: Lower limb telangiectasia.; Hereditary hemorrhagic telangiectasia

• Registration Number: IRCT20100314003566N13
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients with facial telangiectasia
Patients with telangiectasia of lower limbs
Consent to participate in the study

Exclusion Criteria

Pregnant and lactating women
Patients with a history of coagulation disorders
Suffering from chronic systemic liver diseases
Patients with a history of hypertrophic scars and prone to keloid

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recovery rate of telangiectasia. Timepoint: Patients will be examined at baseline, 4 weeks after the first treatment, 4 weeks after the second treatment, and 4 weeks after the last evaluation. Method of measurement: Dermoscopy imaging.;Patient satisfaction. Timepoint: Patients will be examined at baseline, 4 weeks after the first treatment, 4 weeks after the second treatment, and 4 weeks after the last evaluation. Method of measurement: Interview with patients.;Side effects. Timepoint: Patients will be examined at baseline, 4 weeks after the first treatment, 4 weeks after the second treatment, and 4 weeks after the last evaluation. Method of measurement: Including wounds, scars, erythema, hyperpigmentation, hypopigmentation and blisters, which will be evaluated by a clinical examination by a dermatologist.